As of 9:30 AM on the 10th, Daewoong Pharmaceutical is trading at 115,500 KRW, down 1.28% from the previous day. This represents a 14.44% decline compared to August 6. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling drugs such as Urusa and Albis.
Over the past five days, individual investors have net purchased 145,422 shares, while foreigners and institutions have net sold 67,688 shares and 66,349 shares, respectively.
On July 31, Daewoong Pharmaceutical was an issue in the market due to its "weakness following a second-quarter deficit turnaround."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
